Seelos Therapeutics Stock Price on September 24, 2024
| SEEL Stock | USD 0.39 0.11 22.00% |
If you're considering investing in Seelos OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Seelos Therapeutics stands at 0.39, as last reported on the 17th of December 2024, with the highest price reaching 0.50 and the lowest price hitting 0.37 during the day. Seelos Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.23, which indicates the firm had a -0.23% return per unit of risk over the last 3 months. Seelos Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Seelos Therapeutics' Coefficient Of Variation of (389.04), variance of 172.31, and Risk Adjusted Performance of (0.18) to confirm the risk estimate we provide.
Seelos OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Seelos |
Sharpe Ratio = -0.2253
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SEEL |
Estimated Market Risk
| 15.08 actual daily | 96 96% of assets are less volatile |
Expected Return
| -3.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Seelos Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seelos Therapeutics by adding Seelos Therapeutics to a well-diversified portfolio.
Related Headline
Eliem Therapeutics Headline on 24th of September 2024
500,000 Shares in Eliem Therapeutics, Inc. Acquired by Ally ... by news.google.com
500,000 Shares in Eliem Therapeutics, Inc. Acquired by Ally Bridge Group NY LLC MarketBeat
Seelos Therapeutics Valuation on September 24, 2024
It is possible to determine the worth of Seelos Therapeutics on a given historical date. On September 24, 2024 Seelos was worth 6.36 at the beginning of the trading date compared to the closed value of 4.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Seelos Therapeutics otc stock. Still, in general, we apply an absolute valuation method to find Seelos Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Seelos Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Seelos Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.04 | 3.29 | 2.96 | 3.04 | 592,815 | |
09/24/2024 | 6.36 | 8.86 | 4.48 | 4.78 | 335,516,676 |
| 4.58 | 5.42 | 4.05 | 5.41 | 29,699,494 |
| Backtest Seelos Therapeutics | | | Seelos Therapeutics History | | | Seelos Therapeutics Valuation | Previous | Next |
Seelos Therapeutics Trading Date Momentum on September 24, 2024
| On September 25 2024 Seelos Therapeutics was traded for 5.41 at the closing time. The top price for the day was 5.42 and the lowest listed price was 4.05 . The trading volume for the day was 29.7 M. The trading history from September 25, 2024 was a factor to the next trading day price upswing. The trading price change against the next closing price was 13.18% . The trading price change against the current closing price is 36.40% . |
Seelos Therapeutics Fundamentals Correlations and Trends
By evaluating Seelos Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Seelos Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Seelos financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Seelos Therapeutics OTC Stock history
Seelos Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seelos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seelos Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seelos Therapeutics stock prices may prove useful in developing a viable investing in Seelos Therapeutics
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York. Seelos Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.
Seelos Therapeutics OTC Stock Technical Analysis
Seelos Therapeutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Seelos Therapeutics Period Price Range
Low | December 17, 2024
| High |
0.00 | 0.00 |
Seelos Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Seelos Therapeutics December 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Seelos Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Seelos Therapeutics shares will generate the highest return on investment. By undertsting and applying Seelos Therapeutics otc stock market strength indicators, traders can identify Seelos Therapeutics entry and exit signals to maximize returns
Seelos Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Seelos Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seelos OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seelos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (3.06) | |||
| Total Risk Alpha | (4.75) | |||
| Treynor Ratio | 0.7905 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Seelos OTC Stock
Seelos Therapeutics financial ratios help investors to determine whether Seelos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seelos with respect to the benefits of owning Seelos Therapeutics security.